Cytokine-in-adjuvant steering of the immune response phenotype to HIV-1 vaccine constructs: granulocyte-macrophage colony-stimulating factor and TNF-alpha synergize with IL-12 to enhance induction of cytotoxic T lymphocytes
- PMID: 9103465
Cytokine-in-adjuvant steering of the immune response phenotype to HIV-1 vaccine constructs: granulocyte-macrophage colony-stimulating factor and TNF-alpha synergize with IL-12 to enhance induction of cytotoxic T lymphocytes
Abstract
To enhance and steer immune responses to synthetic peptide vaccines toward selected functional types and to understand the cooperative action of cytokines in fine-tuning the immune response, we attempted to influence the in vivo cytokine environment by delivering cytokines directly to the microenvironment in which the immune response is initiated. Here we study the effects of IL-2, IL-4, IL-7, IL-1beta, IL-12, IFN-gamma, TNF-alpha, and granulocyte-macrophage CSF (GM-CSF) incorporated with peptide in adjuvant on a variety of responses elicited: CTL, T cell proliferation, cytokine production and message, and Ab isotype. We show GM-CSF to be the single most effective cytokine for enhancing both cellular and humoral immunity to two previously characterized HIV-1 MN vaccine constructs. Novel synergies were also detected. GM-CSF synergized with IL-12 for CTL induction in BALB/c mice concomitant with suppression of Th2 cytokines IL-4 and IL-10. TNF-alpha also synergized with IL-12, but by a different mechanism, inducing IFN-gamma production in BALB/c mice and thus shifting the response to a Th1 phenotype. The results presented here suggest that in addition to IL-2, optimum induction of CD8+ CTL in vivo requires a combination of cytokines, including GM-CSF (probably acting to enhance Ag presentation and CD4+ cell help) and IL-12 (steering the Th response toward Th1 cytokines).
Similar articles
-
The boosting effect of co-transduction with cytokine genes on cancer vaccine therapy using genetically modified dendritic cells expressing tumor-associated antigen.Int J Oncol. 2006 Apr;28(4):947-53. Int J Oncol. 2006. PMID: 16525645
-
Effect of immunological adjuvants: GM-CSF (granulocyte-monocyte colony stimulating factor) and IL-23 (interleukin-23) on immune responses generated against hepatitis C virus core DNA vaccine.Cytokine. 2009 Apr;46(1):43-50. doi: 10.1016/j.cyto.2008.12.007. Epub 2009 Mar 10. Cytokine. 2009. PMID: 19278866
-
Enhancement of cellular and humoral immune responses to hepatitis C virus core protein using DNA-based vaccines augmented with cytokine-expressing plasmids.J Immunol. 1997 Feb 1;158(3):1231-7. J Immunol. 1997. PMID: 9013964
-
[Up-to-date understanding of tuberculosis immunity].Kekkaku. 2003 Jan;78(1):51-5. Kekkaku. 2003. PMID: 12683337 Review. Japanese.
-
Cytokine circuits in brain. Implications for AIDS dementia complex.Res Publ Assoc Res Nerv Ment Dis. 1994;72:71-88. Res Publ Assoc Res Nerv Ment Dis. 1994. PMID: 8115722 Review.
Cited by
-
Strategies to use immune modulators in therapeutic vaccines against cancer.Semin Oncol. 2012 Jun;39(3):348-57. doi: 10.1053/j.seminoncol.2012.02.002. Semin Oncol. 2012. PMID: 22595057 Free PMC article. Review.
-
Maximizing CD8+ T cell responses elicited by peptide vaccines containing CpG oligodeoxynucleotides.Clin Immunol. 2007 Aug;124(2):119-30. doi: 10.1016/j.clim.2007.04.003. Epub 2007 Jun 21. Clin Immunol. 2007. PMID: 17584532 Free PMC article.
-
Vaccines, Adjuvants, and Dendritic Cell Activators--Current Status and Future Challenges.Semin Oncol. 2015 Aug;42(4):549-61. doi: 10.1053/j.seminoncol.2015.05.006. Epub 2015 Jun 3. Semin Oncol. 2015. PMID: 26320060 Free PMC article. Review.
-
Soluble mediators of inflammation in HIV and their implications for therapeutics and vaccine development.Cytokine Growth Factor Rev. 2012 Aug-Oct;23(4-5):193-206. doi: 10.1016/j.cytogfr.2012.05.006. Epub 2012 Jun 27. Cytokine Growth Factor Rev. 2012. PMID: 22743035 Free PMC article. Review.
-
High-affinity T helper epitope induces complementary helper and APC polarization, increased CTL, and protection against viral infection.J Clin Invest. 2001 Dec;108(11):1677-85. doi: 10.1172/JCI13463. J Clin Invest. 2001. PMID: 11733563 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Research Materials